Treatment of neuromyelitis optica with rituximab: a 2-year prospective multicenter study
Philippe Cabre
(1)
,
M. Mejdoubi
(2)
,
S. Jeannin
(1)
,
H. Merle
(3)
,
Y. Plumelle
(4)
,
G. Cavillon
(5)
,
D. Smadja
(1)
,
R. Marignier
(5)
1
Department of Neurology, Pierre Zobda-Quitman University Hospital, Fort de France
2 Department of Radiology, Pierre Zobda-Quitman University Hospital, Fort de France
3 Department of Ophthalmology, Pierre Zobda-Quitman University Hospital, Fort de France
4 Department of Biological Hematology, Pierre Zobda-Quitman University Hospital, Fort de France
5 Department of Neurology, Pierre-Wertheimer Hospital, Civilian Hospices of Lyon, Lyon
2 Department of Radiology, Pierre Zobda-Quitman University Hospital, Fort de France
3 Department of Ophthalmology, Pierre Zobda-Quitman University Hospital, Fort de France
4 Department of Biological Hematology, Pierre Zobda-Quitman University Hospital, Fort de France
5 Department of Neurology, Pierre-Wertheimer Hospital, Civilian Hospices of Lyon, Lyon